Anar al contingut
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • Current State of the Developme...
  • Citar
  • Enviar aquest missatge de text
  • Enviar per correu electrònic aquest
  • Imprimir
  • Exportar registre
    • Exportar a RefWorks
    • Exportar a EndNoteWeb
    • Exportar a EndNote
  • Enllaç permanent
Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Nowadays vaccination of the population living in the endemic regions and widespread implementation of the potent therapies for the emergency prophylaxis and treatment into the clinical practice are regarded as the basic efficient and cost-effective measures for Ebola epidemic spread control. Objecti...

Descripció completa

Dades bibliogràfiques
Autors principals: A. A. Petrov, V. N. Lebedev, T. M. Plekhanova, L. F. Stovba, G. V. Borisevich, O. N. Sidorova, O. V. Chukhralya, S. V. Borisevich
Format: Article
Idioma:Russian
Publicat: Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2015-09-01
Col·lecció:Проблемы особо опасных инфекций
Matèries:
вирус эбола
лекарственные средства
экстренная профилактика и лечение
вирусспецифические антитела
моноклональные антитела
малые интерферирующие рнк
антисмысловые фосфордиамидатные морфолиновые олигомеры
ebola virus
hemorrhagic fever
medical products
emergency prophylaxis and treatment
virus-specific antibodies
monoclonal antibodies
small interfering rna
anti-sense phosphordiamidate morpholine oligomers
Accés en línia:https://journal.microbe.ru/jour/article/view/254
  • Fons
  • Descripció
  • Ítems similars
  • Visualització del personal

Internet

https://journal.microbe.ru/jour/article/view/254

Ítems similars

  • Monoclonal Antibodies and Recombinant Proteins for Immune-Diagnostics of Ebola Virus Disease
    per: E. I. Kazachinskaya, et al.
    Publicat: (2015-09-01)
  • “CAMEL” ANTIBODIES: FEATURES OF THEIR STRUCTURE, PREPARATION AND APPLICATION
    per: Alexey Alekseevich Andreev, et al.
    Publicat: (2020-06-01)
  • Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases
    per: A. A. Petrov, et al.
    Publicat: (2020-05-01)
  • New Monoclonal Antibodies for the Diagnosis of Influenza and other Acute Respiratory Viral Infections
    per: A. A. Sominina, et al.
    Publicat: (2015-10-01)
  • Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
    per: A. V. Philippova, et al.
    Publicat: (2019-10-01)

Opcions de cerca

  • Historial de cerca
  • Cerca avançada

Trobar-ne més

  • Explorar el catàleg
  • Explorar alfabèticament
  • Explora canals
  • Bibliografia recomanada
  • Nous ítems

Necessites ajuda?

  • Consells de cerca
  • Pregunteu al bibliotecari
  • FAQs